[ad_1]
A new study published in the journal Oncogene showed that mice cancer that has been treated with cannabidiol (CBD) and chemotherapy had an improved survival rate of three times those who been treated with chemotherapy alone, reports Science Daily .
According to the American Cancer Society, approximately 55,440 Americans will be diagnosed with pancreatic cancer by 2018. Of those diagnosed, it is estimated that approximately 44,330 will die. The disease accounts for about 3% of all US cancers and about 7% of cancer deaths. Alternatively, the article says that about 9,800 people are diagnosed with pancreatic cancer in the UK each year.
The study conducted by Queen Mary University of London and Curtin University in Australia tested the impact of CBD on the use of Gemcitabine, a chemotherapy drug commonly used.
Professor Marco Falasca of Queen Mary University in London and senior researcher described the results as "outstanding".
"Cannabidiol is already approved for clinics, which means that we can test it quickly in human clinical trials. If we can reproduce these effects in humans, cannabidiol could be used almost immediately in cancer clinics, compared with the authorities' expectation to approve a new drug. "
Falasca's Commentary on the Use of CBD in Clinics at UK Clinics According to MSN the Food and Drug Administration has just approved the first drug-based CBD based on the prescription in the United States to specifically treat two rare forms of epilepsy last month.
The five-year survival rate for people with pancreatic cancer is less than 7%, the discovery new treatments and therapeutic strategies are urgent. "
CBD does not contain tetrahydrocannabinol (THC) present in cannabis and responsible for the associated psychoactive effects. In simple terms, cannabis makes you tall. The researchers said that CBD could improve the quality of life of pancreatic cancer patients and cancer patients undergoing general chemotherapy because it is known to improve or reduce the side effects associated with chemotherapy. like nausea, vomiting and diarrhea.
However, Science Daily notes, results from this recent British study are currently associated with pancreatic cancer in mice only. Clinical trials are still needed to determine whether the use of CBD in conjunction with chemotherapy treatments would improve life expectancy rates for humans with pancreatic cancer.
If you or someone know a cancer, click here for programs and services in your area
[ad_2]
Source link